Palvella Therapeutics (PVLA) Receivables - Net (2013 - 2024)

Palvella Therapeutics (PVLA) has 11 years of Receivables - Net data on file, last reported at $358000.0 in Q4 2024.

• On a quarterly basis, Receivables - Net changed N/A year-over-year to $358000.0 in Q4 2024; TTM through Dec 2024 was $358000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $358000.0, changed N/A from the prior year.
• Receivables - Net for Q4 2024 stood at $358000.0, down from $373000.0 in the prior quarter.
• Over the last five years, Receivables - Net for PVLA reached as high as $15.8 million in Q1 2021 and fell as low as $358000.0 in Q4 2024.
• Historically, Receivables - Net has averaged $3.6 million across 5 years, with a median of $1.7 million in 2020.
• Across the five-year window, Receivables - Net surged 125.75% in 2021 and tumbled 89.6% in 2022, its largest moves.
• Year by year, Receivables - Net stood at $1.7 million in 2020, then soared by 94.2% to $3.3 million in 2021, then surged by 75.37% to $5.8 million in 2022, then slumped by 82.01% to $1.0 million in 2023, then tumbled by 65.74% to $358000.0 in 2024.
• Per Business Quant data, the three most recent Receivables - Net figures were $358000.0 in Q4 2024, $373000.0 in Q3 2024, and $1.5 million in Q2 2024.